Santhera Pharmaceuticals Holding AG
SANN
Rangering i aksjer
#16269
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Aksjekurs
$18.73
Sist synkronisert: 2026-10-19
Markedsverdi
$286.57M
Endring (1 dag)
-0.14%
Endring (1 år)
44.09%
Land
CH
Handel Santhera Pharmaceuticals Holding AG (SANN)
Kategori
Healthcare
Markedsverdi av Santhera Pharmaceuticals Holding AG(SANN)
Markedsverdi: $286.57M
Per October 2026 har Santhera Pharmaceuticals Holding AG en markedsverdi på $286.57M. Dette gjør Santhera Pharmaceuticals Holding AG til det 16269th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Santhera Pharmaceuticals Holding AG fra 2014 til 2026
SANN sammenlignet med topp 5 mest populære stocks
